Molecular

The QIAstat-Dx is a fully integrated diagnostic system that uses RT-PCR technology to detect syndromic respiratory infections. The system can perform multiple tests simultaneously and provides results in approximately one hour.  

​

This allows hospitals to adapt and respond quickly to different needs and outbreaks. It is easy to use, allowing laboratories to deploy and operate the platform quickly and easily. This reduces reliance on specialized skills and facilitates integration into the laboratory's existing workflow.

​

​Unlike other rapid molecular platforms, the kit provides Ct (cycle threshold) values of amplification curves to assist in the interpretation of test results, determination of viral or bacterial load, and evaluation of the effectiveness of the treatment. Helps hospitals improve patient care, optimize resources, and make more accurate treatment decisions.